Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Mosser

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Oncology|March 28, 2020
Implementation of a molecular tumor board at a regional level to improve access to targeted therapyHéloïse Bourien, Alexandra Lespagnol, Boris Campillo-Gimenez, et al.
Targeted Oncology|May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line TherapySolène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.
The European Respiratory Journal|August 12, 2017
EGFR tyrosine kinase inhibitors <i>versus</i> chemotherapy in <i>EGFR</i> wild-type pre-treated advanced nonsmall cell lung cancer in daily practicePascale Tomasini, Solenn Brosseau, Julien Mazières, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2017
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers FranceNicolas Guibert, Fabrice Barlesi, Renaud Descourt, et al.
International Journal of Cancer|September 14, 2016
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potentialSolène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2019
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France studySébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, et al.
European Journal of Medical Genetics|November 3, 2009
Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French seriesSylvie Jaillard, Séverine Drunat, Claude Bendavid, et al.
European Journal of Medical Genetics|November 25, 2010
Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardationChristèle Dubourg, Damien Sanlaville, Martine Doco-Fenzy, et al.
EMBO Molecular Medicine|February 8, 2023
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Oncology|March 28, 2020
Implementation of a molecular tumor board at a regional level to improve access to targeted therapyHéloïse Bourien, Alexandra Lespagnol, Boris Campillo-Gimenez, et al.
Targeted Oncology|May 28, 2017
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line TherapySolène-Florence Kammerer-Jacquet, Sarah Medane, Karim Bensalah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.
The European Respiratory Journal|August 12, 2017
EGFR tyrosine kinase inhibitors <i>versus</i> chemotherapy in <i>EGFR</i> wild-type pre-treated advanced nonsmall cell lung cancer in daily practicePascale Tomasini, Solenn Brosseau, Julien Mazières, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2017
Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers FranceNicolas Guibert, Fabrice Barlesi, Renaud Descourt, et al.
International Journal of Cancer|September 14, 2016
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potentialSolène-Florence Kammerer-Jacquet, Laurence Crouzet, Angélique Brunot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2019
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France studySébastien Couraud, Fabrice Barlesi, Clara Fontaine-Deraluelle, et al.
European Journal of Medical Genetics|November 3, 2009
Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French seriesSylvie Jaillard, Séverine Drunat, Claude Bendavid, et al.
European Journal of Medical Genetics|November 25, 2010
Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardationChristèle Dubourg, Damien Sanlaville, Martine Doco-Fenzy, et al.
EMBO Molecular Medicine|February 8, 2023
Dual IRE1 RNase functions dictate glioblastoma developmentStéphanie Lhomond, Tony Avril, Nicolas Dejeans, et al.
Pageof 10